💪

CJC-1295 (with DAC)

Also known as: CJC-1295 DAC, Modified GRF(1-29) with DAC

Well ResearchedGrowth Hormone Optimization

How It Works

Growth hormone releasing hormone (GHRH) analog with Drug Affinity Complex (DAC) that extends half-life to ~8 days. Stimulates pituitary to release GH in a pulsatile fashion.

What It's Used For

Anti-agingFat lossMuscle growthRecoverySleep qualityCollagen synthesis

Administration

Route: Subcutaneous injection
Typical Cycle: 12-16 weeks on, 4-8 weeks off

Safety & Side Effects

Possible Side Effects

  • Water retention
  • Tingling/numbness in extremities
  • Increased hunger
  • Flushing

Contraindications

  • Active cancer
  • Pregnancy
  • Pituitary disorders
  • Diabetes (monitor closely)

Research Summary

Modified GHRH analog shown to increase IGF-1 levels by 200-300% in clinical studies. DAC modification extends half-life allowing less frequent dosing.

References

  • Teichman SL et al. J Clin Endocrinol Metab. 2006

Legal & Availability

Research chemical / Compounding pharmacy with prescription

Dosing Protocol

Standard: 2mg/week

Frequency: 1-2x per week

Timing: Before bed

Notes: DAC version provides sustained GH elevation

🔒

Unlock Full Dosing Protocol

Specific dosing, frequency, timing, cycling schedules, and stacking guidance are available with a BioRoot AI Pro subscription.

Stacks Well With

Full stacking protocols and cycling schedules available with Pro subscription.

Is CJC-1295 (with DAC) Right for You?

Our AI analyzes your symptoms, labs, and medical history to determine if this peptide fits your protocol — and at what dose.

Is CJC-1295 (with DAC) right for you?

Get a free personalized analysis based on your symptoms and goals — delivered to your inbox.

This information is for educational purposes only and is not medical advice. Do not use any peptide without consulting a qualified healthcare provider. BioRoot AI is a clinical decision support tool — not a medical provider.